Chronic  ||| S:0 E:8 ||| JJ
wounds ||| S:8 E:14 ||| NNS
:  ||| S:14 E:16 ||| :
differential  ||| S:16 E:29 ||| JJ
diagnosis  ||| S:29 E:39 ||| NN
Wound  ||| S:39 E:45 ||| NNP
is  ||| S:45 E:48 ||| VBZ
a  ||| S:48 E:50 ||| DT
disruption  ||| S:50 E:61 ||| NN
of  ||| S:61 E:64 ||| IN
anatomic  ||| S:64 E:73 ||| NN
and  ||| S:73 E:77 ||| CC
physiologic  ||| S:77 E:89 ||| JJ
continuity  ||| S:89 E:100 ||| NN
of  ||| S:100 E:103 ||| IN
the  ||| S:103 E:107 ||| DT
skin ||| S:107 E:111 ||| NN
.  ||| S:111 E:113 ||| .
According  ||| S:113 E:123 ||| VBG
to  ||| S:123 E:126 ||| TO
the  ||| S:126 E:130 ||| DT
healing  ||| S:130 E:138 ||| NN
process ||| S:138 E:145 ||| NN
,  ||| S:145 E:147 ||| ,
wounds  ||| S:147 E:154 ||| NNS
are  ||| S:154 E:158 ||| VBP
classified  ||| S:158 E:169 ||| VBN
as  ||| S:169 E:172 ||| IN
acute  ||| S:172 E:178 ||| JJ
and  ||| S:178 E:182 ||| CC
chronic  ||| S:182 E:190 ||| JJ
wounds ||| S:190 E:196 ||| NNS
.  ||| S:196 E:198 ||| .
A  ||| S:198 E:200 ||| DT
wound  ||| S:200 E:206 ||| NN
is  ||| S:206 E:209 ||| VBZ
considered  ||| S:209 E:220 ||| VBN
chronic  ||| S:220 E:228 ||| NN
if  ||| S:228 E:231 ||| IN
standard  ||| S:231 E:240 ||| JJ
medical  ||| S:240 E:248 ||| JJ
procedures  ||| S:248 E:259 ||| NNS
do  ||| S:259 E:262 ||| VBP
not  ||| S:262 E:266 ||| RB
lead  ||| S:266 E:271 ||| VB
to  ||| S:271 E:274 ||| TO
the  ||| S:274 E:278 ||| DT
expected  ||| S:278 E:287 ||| JJ
healing ||| S:287 E:294 ||| NN
,  ||| S:294 E:296 ||| ,
or  ||| S:296 E:299 ||| CC
if  ||| S:299 E:302 ||| IN
the  ||| S:302 E:306 ||| DT
wound  ||| S:306 E:312 ||| NN
does  ||| S:312 E:317 ||| VBZ
not  ||| S:317 E:321 ||| RB
heal  ||| S:321 E:326 ||| VB
within  ||| S:326 E:333 ||| IN
six  ||| S:333 E:337 ||| CD
weeks ||| S:337 E:342 ||| NNS
.  ||| S:342 E:344 ||| .
Chronic  ||| S:344 E:352 ||| JJ
wounds  ||| S:352 E:359 ||| NNS
are  ||| S:359 E:363 ||| VBP
classified  ||| S:363 E:374 ||| VBN
as  ||| S:374 E:377 ||| IN
typical  ||| S:377 E:385 ||| JJ
and  ||| S:385 E:389 ||| CC
atypical ||| S:389 E:397 ||| NN
.  ||| S:397 E:399 ||| .
Typical  ||| S:399 E:407 ||| JJ
wounds  ||| S:407 E:414 ||| NNS
include  ||| S:414 E:422 ||| VBP
ischemic ||| S:422 E:430 ||| VBN
,  ||| S:430 E:432 ||| ,
neurotrophic  ||| S:432 E:445 ||| NN
and  ||| S:445 E:449 ||| CC
hypostatic  ||| S:449 E:460 ||| JJ
wounds ||| S:460 E:466 ||| NNS
.  ||| S:466 E:468 ||| .
Diabetic  ||| S:468 E:477 ||| JJ
foot  ||| S:477 E:482 ||| NN
and  ||| S:482 E:486 ||| CC
decubitus  ||| S:486 E:496 ||| JJ
ulcers  ||| S:496 E:503 ||| NNS
stand  ||| S:503 E:509 ||| VBP
out  ||| S:509 E:513 ||| RP
as  ||| S:513 E:516 ||| IN
a  ||| S:516 E:518 ||| DT
specific  ||| S:518 E:527 ||| JJ
entity  ||| S:527 E:534 ||| NN
among  ||| S:534 E:540 ||| IN
typical  ||| S:540 E:548 ||| JJ
wounds ||| S:548 E:554 ||| NNS
.  ||| S:554 E:556 ||| .
About  ||| S:556 E:562 ||| IN
80  ||| S:562 E:565 ||| CD
percent  ||| S:565 E:573 ||| NN
of  ||| S:573 E:576 ||| IN
chronic  ||| S:576 E:584 ||| JJ
wounds  ||| S:584 E:591 ||| NNS
localized  ||| S:591 E:601 ||| VBN
on  ||| S:601 E:604 ||| IN
lower  ||| S:604 E:610 ||| JJR
leg  ||| S:610 E:614 ||| NNS
are  ||| S:614 E:618 ||| VBP
the  ||| S:618 E:622 ||| DT
result  ||| S:622 E:629 ||| NN
of  ||| S:629 E:632 ||| IN
chronic  ||| S:632 E:640 ||| JJ
venous  ||| S:640 E:647 ||| JJ
insufficiency ||| S:647 E:660 ||| NN
,  ||| S:660 E:662 ||| ,
in  ||| S:662 E:665 ||| IN
5-10  ||| S:665 E:670 ||| JJ
percent  ||| S:670 E:678 ||| NN
the  ||| S:678 E:682 ||| DT
cause  ||| S:682 E:688 ||| NN
is  ||| S:688 E:691 ||| VBZ
of  ||| S:691 E:694 ||| IN
arterial  ||| S:694 E:703 ||| JJ
etiology ||| S:703 E:711 ||| NN
,  ||| S:711 E:713 ||| ,
whereas  ||| S:713 E:721 ||| IN
the  ||| S:721 E:725 ||| DT
remainder  ||| S:725 E:735 ||| NN
are  ||| S:735 E:739 ||| VBP
mostly  ||| S:739 E:746 ||| RB
neuropathic  ||| S:746 E:758 ||| JJ
ulcers ||| S:758 E:764 ||| NNS
.  ||| S:764 E:766 ||| .
About  ||| S:766 E:772 ||| IN
95  ||| S:772 E:775 ||| CD
percent  ||| S:775 E:783 ||| NN
of  ||| S:783 E:786 ||| IN
chronic  ||| S:786 E:794 ||| JJ
wounds  ||| S:794 E:801 ||| NNS
manifest  ||| S:801 E:810 ||| VBP
as  ||| S:810 E:813 ||| IN
one  ||| S:813 E:817 ||| CD
of  ||| S:817 E:820 ||| IN
the  ||| S:820 E:824 ||| DT
above-mentioned  ||| S:824 E:840 ||| JJ
entities ||| S:840 E:848 ||| NNS
.  ||| S:848 E:850 ||| .
Other  ||| S:850 E:856 ||| JJ
forms  ||| S:856 E:862 ||| NNS
of  ||| S:862 E:865 ||| IN
chronic  ||| S:865 E:873 ||| JJ
wounds  ||| S:873 E:880 ||| NNS
are  ||| S:880 E:884 ||| VBP
atypical  ||| S:884 E:893 ||| JJ
chronic  ||| S:893 E:901 ||| JJ
wounds ||| S:901 E:907 ||| NNS
,  ||| S:907 E:909 ||| ,
which  ||| S:909 E:915 ||| WDT
can  ||| S:915 E:919 ||| MD
be  ||| S:919 E:922 ||| VB
caused  ||| S:922 E:929 ||| VBN
by  ||| S:929 E:932 ||| IN
autoimmune  ||| S:932 E:943 ||| JJ
disorders ||| S:943 E:952 ||| NNS
,  ||| S:952 E:954 ||| ,
infectious  ||| S:954 E:965 ||| JJ
diseases ||| S:965 E:973 ||| NNS
,  ||| S:973 E:975 ||| ,
vascular  ||| S:975 E:984 ||| JJ
diseases  ||| S:984 E:993 ||| NNS
and  ||| S:993 E:997 ||| CC
vasculopathies ||| S:997 E:1011 ||| NN
,  ||| S:1011 E:1013 ||| ,
metabolic  ||| S:1013 E:1023 ||| NN
and  ||| S:1023 E:1027 ||| CC
genetic  ||| S:1027 E:1035 ||| JJ
diseases ||| S:1035 E:1043 ||| NNS
,  ||| S:1043 E:1045 ||| ,
neoplasm ||| S:1045 E:1053 ||| NN
,  ||| S:1053 E:1055 ||| ,
external  ||| S:1055 E:1064 ||| JJ
factors ||| S:1064 E:1071 ||| NNS
,  ||| S:1071 E:1073 ||| ,
psychiatric  ||| S:1073 E:1085 ||| JJ
disorders ||| S:1085 E:1094 ||| NNS
,  ||| S:1094 E:1096 ||| ,
drug  ||| S:1096 E:1101 ||| NN
related  ||| S:1101 E:1109 ||| VBN
reactions ||| S:1109 E:1118 ||| NNS
,  ||| S:1118 E:1120 ||| ,
etc ||| S:1120 E:1123 ||| FW
.  ||| S:1123 E:1125 ||| .
Numerous  ||| S:1125 E:1134 ||| JJ
systemic  ||| S:1134 E:1143 ||| JJ
diseases  ||| S:1143 E:1152 ||| NNS
can  ||| S:1152 E:1156 ||| MD
present  ||| S:1156 E:1164 ||| VB
with  ||| S:1164 E:1169 ||| IN
atypical  ||| S:1169 E:1178 ||| JJ
wounds ||| S:1178 E:1184 ||| NNS
.  ||| S:1184 E:1186 ||| .
The  ||| S:1186 E:1190 ||| DT
primary  ||| S:1190 E:1198 ||| JJ
cause  ||| S:1198 E:1204 ||| NN
of  ||| S:1204 E:1207 ||| IN
the  ||| S:1207 E:1211 ||| DT
wound  ||| S:1211 E:1217 ||| NN
can  ||| S:1217 E:1221 ||| MD
be  ||| S:1221 E:1224 ||| VB
either  ||| S:1224 E:1231 ||| DT
systemic  ||| S:1231 E:1240 ||| JJ
disease  ||| S:1240 E:1248 ||| NN
itself  ||| S:1248 E:1255 ||| PRP
( ||| S:1255 E:1256 ||| -LRB-
Crohn ||| S:1256 E:1261 ||| NNP
's  ||| S:1261 E:1264 ||| POS
disease ||| S:1264 E:1271 ||| NN
)  ||| S:1271 E:1273 ||| -RRB-
or  ||| S:1273 E:1276 ||| CC
aberrant  ||| S:1276 E:1285 ||| JJ
immune  ||| S:1285 E:1292 ||| JJ
response  ||| S:1292 E:1301 ||| NN
due  ||| S:1301 E:1305 ||| JJ
to  ||| S:1305 E:1308 ||| TO
systemic  ||| S:1308 E:1317 ||| JJ
disease  ||| S:1317 E:1325 ||| NN
( ||| S:1325 E:1326 ||| -LRB-
pyoderma  ||| S:1326 E:1335 ||| FW
gangrenosum ||| S:1335 E:1346 ||| FW
,  ||| S:1346 E:1348 ||| ,
paraneoplastic  ||| S:1348 E:1363 ||| JJ
syndrome ||| S:1363 E:1371 ||| NN
) ||| S:1371 E:1372 ||| -RRB-
.  ||| S:1372 E:1374 ||| .
Although  ||| S:1374 E:1383 ||| IN
atypical  ||| S:1383 E:1392 ||| JJ
wounds  ||| S:1392 E:1399 ||| NNS
are  ||| S:1399 E:1403 ||| VBP
a  ||| S:1403 E:1405 ||| DT
rare  ||| S:1405 E:1410 ||| JJ
cause  ||| S:1410 E:1416 ||| NN
of  ||| S:1416 E:1419 ||| IN
chronic  ||| S:1419 E:1427 ||| JJ
wounds ||| S:1427 E:1433 ||| NNS
,  ||| S:1433 E:1435 ||| ,
it  ||| S:1435 E:1438 ||| PRP
should  ||| S:1438 E:1445 ||| MD
always  ||| S:1445 E:1452 ||| RB
be  ||| S:1452 E:1455 ||| VB
taken  ||| S:1455 E:1461 ||| VBN
in  ||| S:1461 E:1464 ||| IN
consideration  ||| S:1464 E:1478 ||| NN
during  ||| S:1478 E:1485 ||| IN
diagnostic  ||| S:1485 E:1496 ||| JJ
procedure ||| S:1496 E:1505 ||| NN
.  ||| S:1505 E:1507 ||| .
